Richard Hague
Amministratore Delegato presso REGENETP, INC.
Patrimonio netto: 3 112 $ in data 30/04/2024
Profilo
Richard Hague is currently the President, Chief Executive Officer & Director at RegenETP, Inc. He is also the Chief Executive Officer at PolarityTE MD, Inc. Previously, he held positions as the Senior Director at Genzyme Biosurgery Corp.
from 2001 to 2005, the Chief Commercial Officer at Anika Therapeutics, Inc. from 2015 to 2019, the Vice President-Sales & Marketing at TEI Medical, Inc. from 2004 to 2015, and the VP-Sales, Marketing & Commercial Operations at Sanofi UK from 2011 to 2014.
Mr. Hague obtained his undergraduate degree from the University of Connecticut.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
REGENETP INC.
0.60% | 20/03/2023 | 44 453 ( 0.60% ) | 3 112 $ | 30/04/2024 |
Posizioni attive di Richard Hague
| Società | Posizione | Inizio |
|---|---|---|
| REGENETP, INC. | Amministratore Delegato | 01/09/2021 |
PolarityTE MD, Inc.
 PolarityTE MD, Inc. BiotechnologyHealth Technology PolarityTE MD, Inc. operates as a biotechnology company, which develops and commercializes regenerative tissue products and biomaterials. The company was founded on November 23, 2016 and is headquartered in Salt Lake City, UT. | Amministratore Delegato | - |
Precedenti posizioni note di Richard Hague
| Società | Posizione | Fine |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Corporate Officer/Principal | 05/04/2019 |
TEI Medical, Inc.
 TEI Medical, Inc. BiotechnologyHealth Technology Part of Integra LifeSciences Holdings Corp., TEI Medical, Inc. provides an ideal environment to support cellular repopulation and revascularization processes. The company is based in Waltham, MA. TEI Medical was acquired by Integra LifeSciences Holdings Corp. on July 17, 2015 for $101 million. | Vendite & Marketing | 01/10/2015 |
Sanofi UK
 Sanofi UK Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi UK is a company that manufactures and markets healthcare products. The company is based in Guildford, UK. | Vendite & Marketing | 01/01/2014 |
Genzyme Biosurgery Corp.
 Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/01/2005 |
Formazione di Richard Hague
| University of Connecticut | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| REGENETP, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | Health Technology |
TEI Medical, Inc.
TEI Medical, Inc. BiotechnologyHealth Technology Part of Integra LifeSciences Holdings Corp., TEI Medical, Inc. provides an ideal environment to support cellular repopulation and revascularization processes. The company is based in Waltham, MA. TEI Medical was acquired by Integra LifeSciences Holdings Corp. on July 17, 2015 for $101 million. | Health Technology |
Sanofi UK
Sanofi UK Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi UK is a company that manufactures and markets healthcare products. The company is based in Guildford, UK. | Health Technology |
PolarityTE MD, Inc.
PolarityTE MD, Inc. BiotechnologyHealth Technology PolarityTE MD, Inc. operates as a biotechnology company, which develops and commercializes regenerative tissue products and biomaterials. The company was founded on November 23, 2016 and is headquartered in Salt Lake City, UT. | Health Technology |
- Borsa valori
- Insiders
- Richard Hague
